Antibiotic compounds

US11278025B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11278025-B2
Application numberUS-201816614251-A
CountryUS
Kind codeB2
Filing dateMay 17, 2018
Priority dateMay 17, 2017
Publication dateMar 22, 2022
Grant dateMar 22, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present application provides compounds and methods of treating bacterial infection, including bacterial infection caused by P. acnes.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of Formula (II): or a pharmaceutically acceptable salt thereof, wherein: L 2 is C 1-3 alkylene; each Hal is independently a halogen; R 2a , R 3a , R 4a , and R 5a are each independently selected from H and OH; provided that at least one of R 2a , R 3a , R 4a , and R 5a is OH; and R 2b , R 3b , R 4b , R 5b , R 6b , and R 7b are each independently selected from H, OH, HO—C 1-3 alkylene, and —C(═O)OH. 2. The compound of claim 1 having any one of the following formulae: or pharmaceutically acceptable salt thereof, wherein: wherein R 2b , R 3b , R 4b , R 5b , R 6b , and R 7b are each independently selected from H, OH, and —C(═O)OH. 3. The compound of claim 1 , wherein the compound of Formula (II) is selected from: or a pharmaceutically acceptable salt thereof. 4. A compound having a formula: or a pharmaceutically acceptable salt thereof. 5. The compound of claim 1 , having formula: or a pharmaceutically acceptable salt thereof. 6. The compound of claim 1 , having formula: or a pharmaceutically acceptable salt thereof. 7. The compound of claim 1 , having formula: or a pharmaceutically acceptable salt thereof.

Assignees

Inventors

Classifications

  • having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid  {(cannabinoids A61K31/658)} · CPC title

  • Phenols {(cannabinoids A61K31/658)} · CPC title

  • A01N31/08Primary

    Oxygen or sulfur directly attached to an aromatic ring system · CPC title

  • C07C65/17Primary

    containing rings other than six-membered aromatic rings · CPC title

  • having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom and to a carbon atom of a six-membered aromatic ring wherein at least one ortho-hydrogen atom has been replaced · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11278025B2 cover?
The present application provides compounds and methods of treating bacterial infection, including bacterial infection caused by P. acnes.
Who is the assignee on this patent?
Massachusetts Gen Hospital, Rhode Island Hosp Lifespan Ptr, Univ Temple
What technology area does this patent fall under?
Primary CPC classification A01N31/08. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).